Charting the journey over 365 days of living with GBM
Meaningful clinical responses to tovorafenib suggest an important new tool in the Brain Cancer Toolbox
An important and visionary partnership featuring multiple members of Team Julie
Neurosurgeon "par excellence" and Biotech entrepreneur
Optimizing Immuno-Oncology treatment by overcoming immune-related Adverse Events (irAEs)
We travel to the wedding of a dear friend's daughter in snowy Vermont
Further Evidence that the Central Hypothesis is gaining traction in cancer immunotherapy
Dr. Iyad Alnahhas (Jefferson University Neuro-Oncology) interviews pediatric brain cancer pioneer Dr. David Gutmann (Washington University - St. Louis…
See all

Mission GBM